Evidence map›Paper›PMID 24123812›Full record

ArticleJournal of lipid research2013

Significance of the hydrophobic residues 225-230 of apoA-I for the biogenesis of HDL.

Panagiotis Fotakis, Ioanna Tiniakou, Andreas K Kateifides, Christina Gkolfinopoulou, Angeliki Chroni, Efstratios Stratikos, Vassilis I Zannis, Dimitris Kardassis

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Panagiotis FotakisWhitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118.
Ioanna Tiniakou
Andreas K Kateifides
Christina Gkolfinopoulou
Angeliki Chroni
Efstratios Stratikos
Vassilis I Zannis
Dimitris Kardassis
National Centre of Scientific Research "Demokritos" · GRUniversity of Crete · GRBoston University · US

Funding

MOLECULAR AND FUNCTIONAL ANALYSIS OF HUMAN APOA-IR01HL048739 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ZANNIS, VASSILIS I · 1994 to 2011
$4.3M
NHLBI NIH HHS HL-48739NHLBI NIH HHS R01 HL048739
6 · The paper itself

Abstract

We studied the significance of four hydrophobic residues within the 225-230 region of apoA-I on its structure and functions and their contribution to the biogenesis of HDL. Adenovirus-mediated gene transfer of an apoA-I[F225A/V227A/F229A/L230A] mutant in apoA-I⁻/⁻ mice decreased plasma cholesterol, HDL cholesterol, and apoA-I levels. When expressed in apoA-I⁻/⁻ × apoE⁻/⁻ mice, approximately 40% of the mutant apoA-I as well as mouse apoA-IV and apoB-48 appeared in the VLDL/IDL/LDL. In both mouse models, the apoA-I mutant generated small spherical particles of pre-β- and α4-HDL mobility. Coexpression of the apoA-I mutant and LCAT increased and shifted the-HDL cholesterol peak toward lower densities, created normal αHDL subpopulations, and generated spherical-HDL particles. Biophysical analyses suggested that the apoA-I[225-230] mutations led to a more compact folding that may limit the conformational flexibility of the protein. The mutations also reduced the ability of apoA-I to promote ABCA1-mediated cholesterol efflux and to activate LCAT to 31% and 66%, respectively, of the WT control. Overall, the apoA-I[225-230] mutations inhibited the biogenesis of-HDL and led to the accumulation of immature pre-β- and α4-HDL particles, a phenotype that could be corrected by administration of LCAT.

Indexed as

Hydrophobic and Hydrophilic InteractionsAdenoviridaeAnimalsApolipoprotein A-IChemical PhenomenaHEK293 CellsHumansLipoproteins, HDLMiceMutationApolipoprotein A-ILipoproteins, HDLapolipoprotein A-I mutationsdyslipidemiahigh density lipoprotein biogenesispre-β- and α-HDL particles

Identifiers

PMID24123812
PMCPMC3826677
OpenAlexW2099457911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.